NHS to recruit nurses and midwives before vacancies arise in new jobs boost
NHS providers will be able to begin recruiting before vacancies formally arise as part of a 'graduate guarantee', the Department of Health and Social Care (DHSC) said.
Its change to the recruitment process means trusts will be able to employ new staff based on projected need rather than current headcounts and is intended to ensure there are enough jobs for every newly qualified nurse and midwife in England.
The DHSC said the move will remove barriers from trusts and open up thousands of positions for newly qualified nurses and midwives in the NHS.
It said the package will also ensure the NHS has the right number of staff in hospitals across the country to provide the best possible care for patients.
Further measures in the 'graduate guarantee' include newly qualified students receiving access to an online hub containing important information and advice for their applications to the roles, and an additional £8 million to temporarily convert vacant maternity support worker posts to Band 5 midwifery positions.
The package comes following talks between the Government, the Royal College of Midwives (RCM) and the Royal College of Nursing (RCN).
Record numbers decided to study nursing during the Covid pandemic, and fewer nurses and midwives are leaving the profession, meaning in some areas there are up to three times as many graduates as vacancies.
Health Secretary Wes Streeting said: 'It is absurd that we are training thousands of nurses and midwives every year, only to leave them without a job before their career has started.
'No one who dedicates themselves to a nursing or midwifery career should be left in limbo, when their skills are so urgently needed in the effort to rebuild our NHS.
'I am sending a clear message to every newly qualified nurse and midwife: we're here to support you from day one so you can provide the best care for patients and cut waiting lists.'
The DHSC says it hopes the measures will spread healthcare professionals across a wide variety of sectors.
It cites that there are three times as many graduates as there are vacancies in some parts of the country, creating barriers for newly qualified healthcare professionals seeking jobs.
The Government claims the reforms will provide greater certainty and access to a wide and diverse range of roles, addressing this issue of bottlenecks.
Professor Nicola Ranger, general secretary of the RCN said the success of the scheme will be judged on whether more students are able to fill vacant positions in the NHS.
She said: 'Our student members have led the way in calling for ministers and healthcare leaders to provide certainty and clarity on jobs.
'Today's announcement is welcome news that should provide hope to students as they come towards the end of their education and training.
'When the health service urgently needs nursing staff, it was absurd to leave people in limbo.
'The test of this will be if students can find jobs, vacant posts are filled, and patients receive the care they deserve.'
RCM chief executive Gill Walton said: 'We're pleased that the Government has listened to the voices of student midwives who are desperate to start their career, only to find those opportunities blocked.
'I know today's announcement will come as a relief to so many of the RCM's student midwife members.
'These are people, mainly women, who have worked incredibly hard to complete their degree and are trained and ready to support our current midwifery workforce at a time when so many maternity services are under pressure.
'Ensuring we have the right midwifery staff, in the right places, at the right time with the right education and training has never been so crucial as services are striving to improve safety.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
BBC Radio Scotland's Bryan Burnett to return to airwaves after cancer treatment
BBC Radio Scotland presenter Bryan Burnett will return to the airwaves on Thursday after undergoing cancer treatment. The broadcaster announced in June he would step back from his programme Get It On to receive care for appendix cancer. Fellow presenter Grant Stott, who stepped in during his absence, announced his return to listeners on Tuesday night. He said: 'In what must have been a terrible time for Bryan and his family and close friends, I'm just delighted I was able to help by looking after something that is very precious to Bryan; Get It On and his listeners. 'Getting to do the show over this time has shown me just how close the audience is to Bryan and vice versa. 'I know they will be delighted to get their radio teatime pal back.' Burnett said his treatment had been successful and thanked those who had wished him well throughout his recovery. Commenting on his return, he said: 'I am delighted to be returning to work following successful treatment for appendix cancer. 'Over the past few months I have been focused on my recovery and have been supported by an incredible medical team, my family and friends, and the overwhelming kindness of so many BBC Radio Scotland listeners who have reached out with encouragement and well-wishes. 'Their messages, cards and kindness have meant so much. 'My team at the BBC have also been a huge support and I want to thank Grant Stott, who has been sitting in for me and done such a great job looking after the show. 'My return to work will be gradual to ensure I maintain my health and energy. Cancer has given me a renewed perspective on what matters most and I am excited about the road ahead and grateful for the opportunity to return to doing what I'm passionate about.' Hayley Valentine, director BBC Scotland, said: 'Like the Get it On listeners, everyone at BBC Scotland is delighted to be welcoming Bryan back to the studio following what has been a tough couple of months for him. We look forward to seeing and hearing him back where he belongs.' Stott will share Get it On presenting duties with Bryan during his phased return. Burnett's first Get it On show will be Thursday 14 August 14 6pm to 8pm.
Medscape
24 minutes ago
- Medscape
Violence Against Nurses Surges in ‘Tinderbox' A&Es
Violence against A&E staff in England has almost doubled over the past 5 years, with nursing leaders warning that chronic understaffing, long waits, and corridor care are fuelling the rise. The Royal College of Nursing (RCN) said that more than 4000 incidents of physical violence were recorded in 2024, compared with just over 2000 in 2019. It urged the government to take decisive action, warning that without change its 10-Year Health Plan would 'fail completely'. In one Kent hospital, cases of violence against staff increased by more than 500%, from 13 in 2019 to 89 last year. At a Bristol hospital, incidents almost doubled from 83 to 152 in the same period. Punching, spitting, and acid attack threats were among the behaviours staff in emergency departments regularly face, according to the RCN. The figures came from a Freedom of Information request sent to NHS trusts, with 89 out of a possible 129 trusts responding. Long Waits Fuel Tensions Analysis of NHS data by the RCN also found that waits of more than 12 hours in A&E had risen more than 20-fold over the same period. On a typical working day, a member of emergency department staff in England is attacked every hour, the RCN said. Long delays were also causing anger among patients who were not typically violent. Senior charge nurse Rachelle said that 'even patients you would expect to be placid are becoming irate because of just how long they have to wait'. One senior A&E nurse described her hospital as a 'tinder box' for violence. She had seen colleagues punched, kicked and threatened with a gun, and had herself been spat at and threatened with an acid attack. The incidents caused depression and anxiety, prompting her to take a secondment in research to step away from the frontline. Recruitment Concerns Earlier this week, the government launched a Graduate Guarantee scheme, promising jobs for newly qualified nurses and midwives. However, one nurse warned that the level of violence was unlikely to help with retention or recruitment. 'If you think you're going to be clobbered every shift, why would you stay?' she said. RCN general secretary and chief executive Professor Nicola Ranger said: 'Nursing staff not only go to work underpaid and undervalued but now face a rising tide of violence. It leads to both physical and mental scarring, lengthy time off, and sometimes staff never returning. You can't fix the health service when vital staff are too scared to even go into work.' 'Shocking' Levels of Abuse The 2024 NHS Staff Survey found that 14.38% of staff had experienced at least one incident of physical violence from patients, service users, relatives, or members of the public over the course of a year. A further 25.08% reported at least one incident of harassment, bullying, or abuse. 'Behind these shocking figures lies an ugly truth,' Ranger said. 'Dedicated and hard-working nursing staff face rising violent attacks because of systemic failures that are no fault of their own.' She urged the government to move beyond recording incidents and focus on reducing them. NHS Response NHS England said it was committed to supporting colleagues in violence prevention, security management, and other high-risk roles. It offers courses and programmes to help staff prevent and reduce the risk of violence and to support their wellbeing. 'Measures to keep staff safe day-to-day are crucial,' said Ranger. 'But the stark reality is that unless the government does something about lengthy waits, corridor care, and understaffed nursing teams, more nursing staff will become victims of this utterly abhorrent behaviour.'
Forbes
25 minutes ago
- Forbes
How Collaborations Are Helping London Biotechs Find A Route To Market
Partnerships and collaborations provide an important means for life sciences and healthtech startups to validate their technologies, secure financial backing and navigate a route to market. London, with its concentration of teaching hospitals, universities and research institutions, all sitting in close proximity to local and global VC firm headquarters, may be well placed to nurture the next generation of health innovators. The challenge is to make the most of the existing ecosystem. When it comes down to raising VC finance, Britain's healthtech and life sciences startups are doing rather well. Witness the last set of quarterly figures published by HSBC Innovation Banking and Dealroom. According to the data, healthtech businesses raised $1.8 billion in the first three months of this year, the largest sum since the second quarter of 2021. More than half the money raised went to businesses developing AI solutions. And the government is playing its part in boosting the sector. For instance, earlier this year, Finance Minister Rachel Reeves announced a £29 billion boost for Britain's National Health Service, with £10 billion of that earmarked for investment in new technologies. To underline that point, an initiative dubbed the Innovator Passport will allow digital solutions tested in one health organisation to be rolled out across others without further checks. This could be hugely important in the U.K., where the national health system is administered locally through trusts that tend to work independently of each other. It's all part of a 'Modern Industrial Strategy' plan aimed at helping the U.K. to become a 'world leader' in health-related technologies. All well and good, but small life sciences and healthtech companies still face the challenge of proving the efficacy of their solutions and also demonstrating how they can be integrated into existing clinical systems. The Partnership Solution One way forward for technology-led startups is to partner with bigger players that can provide resources and access to markets that might otherwise be out of reach. David Roblin is CEO and co-founder of Relation Therapeutics, a company that is collaborating with pharmaceutical giant GSK on developing treatments for osteoarthritis and fibrosis. As he explains, the company was established to bring together people from disparate scientific disciplines and working backgrounds, with the aim of developing an interdisciplinary approach to drug discovery. In practical terms this means that biologists working in the field of genomics, cells and tissues are working alongside experts in machine learning and R&D. As Roblin sees it, the collaboration is helping partner GSK to develop treatments for the targeted illnesses more quickly than would otherwise be the case. "Trying to innovate in a big company with established processes is quite a challenge,' says Roblin. "GSK had all the elements but they didn't have the blank sheet of paper to bring the technologies to bear at the right time and at the right pace.' In return, he says, the relationship with GSK has enhanced Relation Therapeutics' profile and credibility. Indeed, Roblin says the deal played an important part in helping his business secure a $65 million Seed round. "The collaboration was quite important in closing the seed round. GSK brought cash, validation and they also brought ideas and a deep understanding of the diseases,' he says, Every partnership is different in terms of the benefits it delivers. Pangaea Data is a U.K.-based company that has developed a platform that can help clinicians identify hard-to-diagnose diseases. This is achieved by using AI to analyse patient symptoms mapped against models created using existing clinical guidelines. The company says the platform has been used to accelerate diagnoses across 42 conditions. Last month, Pangaea Data announced a partnership with AstraZeneca-owned Alexion Pharmaceuticals. Under the arrangement, Pangaea will configure its platform to detect Hypophosphatisia (HPP), a bone-softening genetic disorder. So what does the collaboration deliver? Well as co-founder Vibhor Gupta acknowledges, once a technology solution has been developed, the challenge is to find a pathway through which the product can be introduced to health systems. "There is the question of who will pay for it,' he says. 'That's why the partnership with Alexion is important. They have a treatment for HPP. We can use the partnership to allow health systems to identify patients who are hiding in plain sight. In other words, there is a symbiosis. Alexion has a treatment for the condition. Pangaea provides a means to find patients who are currently undiagnosed and thus slipping through the treatment net. As Gupta explains, pharmaceutical companies are solutions-driven. 'They don't necessarily have all the data they need - health systems have that - but what they do possess is the motivation to close care gaps and get patients to the right treatment or trials,' he says.' A Collaborative Ecosystem The benefits of collaboration extend far beyond commercial relationships between two companies. For instance, there may also be opportunities for life sciences and health-tech startups to work with universities and research institutes, sharing labs, resources and expertise. This kind of collaboration can be arranged and orchestrated across countries and continents if need be, but it can be - to say the least - helpful if potential partners are situated within walking distance of each other and perhaps meeting regularly at the same events. That's the view of Mike Wiseman, Head of Campuses, at business space provider British Land. Included in his company's portfolio is Regents Place, a mix of labs and office spaces situated on London's Euston Road, an area increasingly referred to as the Knowledge Quarter. As Wiseman points out, the district is home to Meta, Google and Deepmind, along with the Francis Crick medical research institute, The Alan Turing Institute (data and AI) , the University of London and a host of science and technology companies. British Land is positioning Regents Place as a campus for AI and health technology. 'We have a community of likeminded people. Some of the most exciting advances in science are at the intersection of different disciplines and we can facilitate that through spaces and events," says Wiseman. To that end, the company has signed a memo of understanding to work with the University of London on events and there is also an arrangement with the Crick Institute that allows startups from Regents to share lab facilities. Wiseman says this bodes well for the future. London still lags Boston as a health tech and life sciences hub but the building blocks are in place. As he points out, in addition to possible collaborators, regulators and investors are also close at hand. 'You also have access to patients through the NHS and the private clinics of Harley Street. There are very few places like this," he adds. Another complex, Triton Square. is due to open shortly. There is a bigger picture. London is part of the so-called Golden Triangle that also includes Oxford and Cambridge and there is collaboration not just within but between cities. However, startups are likely to benefit from being in proximity to sources of support.
